|
VOR Vor Biopharma Inc 1817229 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-219,585,000.00 |
| Balance Sheet |
|
Current Assets
|
$500,778,000.00 |
|
Assets
|
$506,746,000.00 |
|
Current Liabilities
|
$16,077,000.00 |
|
Liabilities
|
$657,170,000.00 |
|
Equity
|
$-150,424,000.00 |
|
Shares Out
|
54185582.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-38,246,000.00 |
|
Investing Cash Flow
|
$-263,237,000.00 |
| Market Analysis |
Market Cap
|
$1,181,245,687.60 |
|
Price
|
$20.75 |
|
PB
|
7.16 |
|
EPS
|
-5.11 |
|
FCF
|
$-38,294,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:27 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:22 |
|
| Apr |
May |
Jun |
| 2026-03-30 |
-70.50 |
|
|
2026-05-13 |
-5.11 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-12.56 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-121.63 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VOR documents filed with the SEC.
VOR Filings
Clear
